Prevail Therapeutics Inc (PRVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | |
| Operating Expenses | 65,803 | 18,809 |
| Operating Income | -65,803 | -18,809 |
| Interest Expense | 0 | 471 |
| Other Income | 2,615 | 193 |
| Pre-tax Income | -63,188 | -19,087 |
| Net Income Continuous | -63,188 | -19,087 |
| Net Income | $-63,188 | $-19,087 |
| EPS Basic Total Ops | -2.22 | -3.71 |
| EPS Basic Continuous Ops | -2.22 | -3.71 |
| EPS Diluted Total Ops | -2.22 | -3.71 |
| EPS Diluted Continuous Ops | -2.22 | -3.71 |
| EPS Diluted Before Non-Recurring Items | -2.22 | N/A |
| EBITDA(a) | $-65,538 | $-18,283 |